IP Verse

High Concentration Monoclonal Antibody Formulations - EP2849723

PATENT ANALYSIS

Patent Details

Grant Date
May 2, 2018
Company
GENENTECH, INC.
Oppositions

BAYER INTELLECTUAL PROPERTY GMBH / BAYER AKTIENGESELLSCHAFT

More patents of Genentech, Inc.

EP2694072

EP2784084

EP3597659

Want to monitor this patent?

Feel free to send us a message here and we will get back to you